SET:BDMS

Stock Analysis Report

Bangkok Dusit Medical Services

Executive Summary

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally.

Snowflake

Fundamentals

Proven track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Bangkok Dusit Medical Services's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.8%

BDMS

-0.1%

TH Healthcare

0.7%

TH Market


1 Year Return

-6.0%

BDMS

-12.1%

TH Healthcare

-5.1%

TH Market


Shareholder returns

BDMSIndustryMarket
7 Day-0.8%-0.1%0.7%
30 Day-3.3%-3.5%-2.3%
90 Day-4.5%-6.9%-6.3%
1 Year-4.3%-6.0%-10.3%-12.1%-2.1%-5.1%
3 Year13.8%8.3%2.6%-2.4%17.0%6.8%
5 Year41.1%30.7%23.5%14.7%15.4%-1.6%

Price Volatility Vs. Market

How volatile is Bangkok Dusit Medical Services's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Bangkok Dusit Medical Services undervalued compared to its fair value and its price relative to the market?

6.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued:

Significantly Undervalued: BDMS is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: BDMS is good value based on its PE Ratio (25.2x) compared to the Healthcare industry average (33.2x).

PE vs Market: BDMS is poor value based on its PE Ratio (25.2x) compared to the TH market (15.3x).


Price to Earnings Growth Ratio

Low PEG Ratio: BDMS's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: BDMS is overvalued based on its PB Ratio (4.7x) compared to the TH Healthcare industry average (2.7x).


Next Steps

Future Growth

How is Bangkok Dusit Medical Services forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?

-4.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BDMS's earnings are forecast to decline over the next 3 years (-4% per year).

Earnings vs Market: BDMS's earnings are forecast to decline over the next 3 years (-4% per year).

High Growth Earnings: BDMS's earnings are forecast to decline over the next 3 years.

Revenue vs Market: BDMS's revenue (7.6% per year) is forecast to grow faster than the TH market (7.3% per year).

High Growth Revenue: BDMS's revenue (7.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Bangkok Dusit Medical Services performed over the past 5 years?

12.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: BDMS's earnings have grown by 12.8% per year over the past 5 years.

Accelerating Growth: BDMS's earnings growth over the past year (54.4%) exceeds its 5-year average (12.8% per year).

Earnings vs Industry: BDMS earnings growth over the past year (54.4%) exceeded the Healthcare industry -8.5%.


Return on Equity

High ROE: BDMS's Return on Equity (18.6%) is considered low.


Return on Assets

ROA vs Industry: BDMS has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: BDMS has not improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Bangkok Dusit Medical Services's financial position?


Financial Position Analysis

Short Term Liabilities: BDMS's short term assets (฿20.3B) do not cover its short term liabilities (฿28.1B)

Long Term Liabilities: BDMS's short term assets (20.3B) do not cover its long term liabilities (25.7B)


Debt to Equity History and Analysis

Debt Level: BDMS's debt to equity ratio (39.9%) is considered satisfactory

Reducing Debt: BDMS's debt to equity ratio has reduced from 53.9% to 39.9% over the past 5 years.

Debt Coverage: BDMS's debt is well covered by operating cash flow (44.6%).

Interest Coverage: BDMS's interest payments on its debt are well covered by EBIT (11x coverage).


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Bangkok Dusit Medical Services's current dividend yield, its reliability and sustainability?

1.88%

Current Dividend Yield


Dividend Yield vs Market

company1.9%marketbottom25%2.2%markettop25%6.3%industryaverage2.1%forecastin3Years1.8%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: BDMS's dividend (1.88%) isn’t notable compared to the bottom 25% of dividend payers in the TH market (2.21%).

High Dividend: BDMS's dividend (1.88%) is low compared to the top 25% of dividend payers in the TH market (6.27%).

Stable Dividend: BDMS's dividend payments have been volatile in the past 10 years.

Growing Dividend: BDMS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (47.4%), BDMS's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: BDMS's dividends in 3 years are forecast to be covered by earnings (55% payout ratio).


Next Steps

Management

What is the CEO of Bangkok Dusit Medical Services's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Bangkok Dusit Medical Services has no CEO, or we have no data on them.


Management Age and Tenure

0.8yrs

Average Tenure

65yo

Average Age

Experienced Management: BDMS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Age and Tenure

10.0yrs

Average Tenure

66.5yo

Average Age

Experienced Board: BDMS's board of directors are considered experienced (10 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Chatree Duangnet (74yo)

    Executive Advisor to CEO & Authorized Director

    • Tenure: 13.5yrs
    • Compensation: ฿5.93m
  • Chuladej Yossundharakul (86yo)

    Vice Chairman

    • Tenure: 0yrs
    • Compensation: ฿6.96m
  • Sripop Sarasas (62yo)

    Chief Administrative Officer & Director

    • Tenure: 11.5yrs
    • Compensation: ฿6.48m
  • Pradit Theekakul (60yo)

    Executive VP of Administration & Executive VP of Corporate Portfolio and Director

    • Tenure: 11.6yrs
    • Compensation: ฿7.06m
  • Narumol Noi-Am (61yo)

    CFO, Acting President & Substituting Director

    • Tenure: 0.8yrs
    • Compensation: ฿250.00k
  • Kessara Wongsekate

    VP & Company Secretary

    • Tenure: 0yrs
  • Trin Charumilind (68yo)

    Chief Medical Officer

    • Tenure: 0yrs
  • Nisa Laohasomboon

    Assistant Chief Finance Officer

    • Tenure: 0yrs
  • Wannapa Pawavech

    Corporate Accounting Director

    • Tenure: 0yrs
  • Chairat Panthuraamphorn

    Chief Operating Officer

    • Tenure: 0.8yrs

Board Members

  • Chatree Duangnet (74yo)

    Executive Advisor to CEO & Authorized Director

    • Tenure: 13.5yrs
    • Compensation: ฿5.93m
  • Chuladej Yossundharakul (86yo)

    Vice Chairman

    • Tenure: 0yrs
    • Compensation: ฿6.96m
  • Santasiri Sornmani (84yo)

    Independent Director

    • Tenure: 25.8yrs
    • Compensation: ฿7.02m
  • Arun Pausawasdi (81yo)

    Independent Chairman

    • Tenure: 0yrs
    • Compensation: ฿8.98m
  • Thongchai Jira-alongkorn (59yo)

    Director

    • Tenure: 7.5yrs
    • Compensation: ฿6.71m
  • Weerawong Chittmittrapap (61yo)

    Independent Director

    • Tenure: 4yrs
    • Compensation: ฿6.50m
  • Sripop Sarasas (62yo)

    Chief Administrative Officer & Director

    • Tenure: 11.5yrs
    • Compensation: ฿6.48m
  • Pradit Theekakul (60yo)

    Executive VP of Administration & Executive VP of Corporate Portfolio and Director

    • Tenure: 11.6yrs
    • Compensation: ฿7.06m
  • Narumol Noi-Am (61yo)

    CFO, Acting President & Substituting Director

    • Tenure: 0.8yrs
    • Compensation: ฿250.00k
  • Chavalit Sethameteekul (71yo)

    Independent Director

    • Tenure: 8.5yrs
    • Compensation: ฿6.91m

Company Information

Bangkok Dusit Medical Services Public Company Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bangkok Dusit Medical Services Public Company Limited
  • Ticker: BDMS
  • Exchange: SET
  • Founded: 1969
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ฿371.873b
  • Shares outstanding: 15.89b
  • Website: https://www.bdms.co.th/

Location

  • Bangkok Dusit Medical Services Public Company Limited
  • 2, Soi Soonvijai 7
  • New Petchburi Road
  • Bangkok
  • 10310
  • Thailand

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDMSSET (The Stock Exchange of Thailand)YesOrdinary SharesTHTHBJan 1992
BDMS-FTHAMSE (Bangkok-Alien Market Stock Exchange)THB0.1 (ALIEN MARKET)THTHBJan 1992
BDUL.FOTCPK (Pink Sheets LLC)THB0.1 (ALIEN MARKET)USUSDJan 1992
6DM1BST (Boerse-Stuttgart)THB0.1 (ALIEN MARKET)DEEURJan 1992
BDMS-RSET (The Stock Exchange of Thailand)THB1(NVDR)THTHBAug 2001
BDUU.FOTCPK (Pink Sheets LLC)THB1(NVDR)USUSDAug 2001
BDUU.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDDec 2012

Biography

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company owns and manages hospital groups, including Bangkok Ho ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 14:31
End of Day Share Price2019/10/11 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.